Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

Posted on September 1, 2023 By Admin No Comments on FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition


The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California.

Mario Tama | Getty Images

The Federal Trade Commission on Friday said it has reached a deal with drug giant Amgen to allow the company’s $27.8 billion purchase of Horizon Therapeutics to move forward. 

The two companies now expect to close the acquisition – Amgen’s largest ever – early in the fourth quarter of this year, a spokesperson for Amgen said.

The agreement resolves a lawsuit the FTC filed in May seeking to block the acquisition over concerns it would allow Amgen to leverage its drug portfolio to stifle competition in the pharmaceutical industry. The agency this week temporarily suspended that suit, which allowed it to consider whether to settle the case. 

But the agreement announced Friday still imposes restrictions on Amgen to address key concerns the FTC raised in its suit.

The deal specifically prohibits Amgen from “bundling” two of Horizon’s blockbuster drugs: thyroid eye disease therapy Tepezza and Krystexxa, a gout medicine.

That practice involves offering rebates or discounts on its existing products to pressure insurers and pharmacy benefit managers into favoring the Horizon products.

Amgen will also have to get approval from the FTC to acquire any products that treat the same diseases as Tepezza and Krystexxa do. Amgen is required to seek those sign offs from the agency through 2032.

All other requirements will be effective for 15 years after the agreement is finalized, according to the FTC.

As part of the deal, attorneys general for California, Illinois, Minnesota, New York, Washington, and Wisconsin have also agreed to dismiss their federal suits seeking to block the merger.

Shares of Horizon rose nearly 3% in early morning trading Friday. Amgen’s stock edged up slightly.

The spokesperson for Amgen said the company has no “reason, ability, or intention” to bundle Horizon’s two fast-growing medications. The new agreement “will have no impact on Amgen’s business,” the spokesperson added.

A Horizon spokesperson did not immediately respond to a request for comment.

Amgen first moved to buy Horizon in December 2022 in an effort to gain access to the latter’s rare disease assets, but buyout was quick to attract regulatory and political scrutiny for its potential antitrust issues.

Sen. Elizabeth Warren, D-Mass., in a letter to FTC Chairwoman Lina Khan asked the regulator to “heavily scrutinize” the acquisition and the then-pending merger of Indivior and Opiant. She warned the deals could lead to higher prices.

The FTC eventually heeded Warren’s warnings and filed its lawsuit.

In a separate statement Friday, Khan said the agency will “continue to challenge unlawful practices that raise drug prices, inhibit access, stifle innovation, or otherwise hurt patients.”

The FTC is currently reviewing Pfizer’s $43 billion acquisition of cancer drug developer Seagen, one of the largest deals of this year. The agency started an in-depth investigation into the transaction in July.

The FTC, under Khan, has challenged a number of high-profile mergers. But the agency has struggled in court this year, losing cases to block a Meta deal and Microsoft’s acquisition of Activision Blizzard.



Source link

Health Tags:Amgen Inc, Biotech and Pharmaceuticals, Biotechnology, Breaking News: Business, Business, business news, Federal Trade Commission, Health care industry, Horizon Therapeutics PLC, Meta Platforms Inc, Microsoft Corp, Pfizer Inc, Pharmaceuticals, Products and Services, Seagen Inc

Post navigation

Previous Post: Ed Ruscha’s ‘Chocolate Room’ Still Tantalizes
Next Post: Pakistan to field same playing XI in India clash as first match – SUCH TV

More Related Articles

Prioritizing Mental Health: 3 Thoughtful Habits For Daily Well-Being Health
WHO recommends new, cheaper malaria vaccine for children – SUCH TV Health
FDA declines to approve Neffy epinephrine nasal spray for severe allergic reactions Health
Supervised toothbrushing expanded to reach schools in poorest areas Health
Surgeon General Calls for Warning Labels on Social Media Platforms Health
Assisted Dying Legislation is ‘Dangerous’ says Archbishop Welby Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Abortion guidelines branded horrifying by grieving mum
  • Woman declared dead by coroner, moved to coffin, turns out to be alive
  • Shohei Ohtani reacts to death of Japanese baseball legend Shigeo Nagashima: ‘May your soul rest in peace’
  • Thames Water nationalisation ‘not the answer’ says minister after rescue bid fails
  • “Family Guy” creator Seth MacFarlane on his other love: Sinatra

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme